Showing items related by title, author, creator and subject.

• Company Stock Prices Before and After Public Announcements Related to Oncology Drugs 

  Rothenstein, Jeffrey M; Tomlinson, George; Tannock, Ian F; Detsky, Allan S (2011-10-19)

  Phase III clinical trials and Food and Drug Administration (FDA) regulatory decisions are critical for success of new drugs and can influence a company's market valuation. Knowledge of trial results before they are made ...